Latest Blog Posts Tagged "National Institutes of Health (NIH)"
March 01, 2017
As part of the Foundation's 2017 Parkinson's Policy Forum, Michael J. Fox met with bipartisan members of the House of Representatives to support policies that impact the PD community.
June 27, 2016
The Safety of Urate Elevation in Parkinson's Disease Phase III study (SURE-PD3) is in the final stage of clinical testing.
November 20, 2015
More than 100 U.S. Representatives ask the House and Senate to work together to increase NIH funding.
September 08, 2015
Using data from the MJFF-led Parkinson's Progression Markers Initiative, NIH researchers have identified five criteria that together may be able to predict who will develop Parkinson's disease.
September 01, 2015
Based on findings from MJFF-funded research, today the Parkinson Study Group announced an NIH grant for a Phase III trial of inosine, a potential disease-modifying treatment for Parkinson's disease.
July 27, 2015
Tanya Simuni, MD, spoke to us about results from a trial of diabetes drug pioglitazone for PD treatment and what her team's findings mean for this vein of Parkinson's research.
October 20, 2014
A clinical trial of a compound with potential to slow disease progression is recruiting newly diagnosed PD patients not yet in need of symptomatic therapy to test the drug's efficacy.
August 07, 2014
MJFF is working with the FDA to define parameters for clinical trials of drugs to treat mild cognitive impairment with Parkinson's disease or PD-MCI.
July 30, 2014
Scientists have found six new gene variants associated with Parkinson's, which could point to new treatment paths.
April 04, 2014
WHAM in Rochester, New York ran a piece on the Phase III study of isradipine happening at the University of Rochester. MJFF funded Phase II.